Genetic study reveals infantile-onset mitochondrial encephalopathy caused by biallelic COX11 mutations, suggesting potential metabolic therapeutic strategies.
. These results not only suggest that COX11 variants cause defects in energy production but reveal a potential metabolic therapeutic strategy for patients with COX11 variants.
No takes yet. Share an insight, caveat, or question.
Rius et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: